NEW YORK, NY / ACCESSWIRE / April 23, 2020 / The Klein Law Firm announces that class action complaints have been filed on behalf of shareholders of the following companies. There is no cost to participate in the suit. If you suffered a loss, you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
Crown Castle International Corp. (NYSE:CCI)
Class Period: February 26, 2018 to February 26, 2020
Lead Plaintiff Deadline: April 27, 2020
The CCI lawsuit alleges that throughout the class period, Crown Castle International Corp. made materially false and/or misleading statements and/or failed to disclose that: 1) Crown Castle's internal control over financial reporting and disclosures controls and procedures were ineffective and materially weak; (2) Crown Castle's financial accounting and reporting was not in accordance with GAAP; (3) Crown Castle's net income, adjusted EBITDA, and AFFO were inflated; (4) Crown Castle would need to restate its financial statements for the years ended December 31, 2018 and 2017, and unaudited financial information for the quarterly and year to-date periods in the year ended December 31, 2018 and for the first three quarters in the year ended December 31, 2019; and (5) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Learn about your recoverable losses in CCI: http://www.kleinstocklaw.com/pslra-1/crown-castle-international-corp-loss-submission-form?id=6164&from=1
Inovio Pharmaceuticals, Inc. (NASDAQ:INO)
Class Period: February 14, 2020 to March 9, 2020
Lead Plaintiff Deadline: May 12, 2020
According to a filed complaint, throughout the class period, defendants made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.
Learn about your recoverable losses in INO: http://www.kleinstocklaw.com/pslra-1/inovio-pharmaceuticals-inc-loss-submission-form?id=6164&from=1
Norwegian Cruise Line Holdings Ltd. (NYSE:NCLH)
Class Period: February 20, 2020 to March 12, 2020
Lead Plaintiff Deadline: May 11, 2020
Throughout the class period, Norwegian Cruise Line Holdings Ltd. allegedly made materially false and/or misleading statements and/or failed to disclose that: (1) the Company was employing sales tactics of providing customers with unproven and/or blatantly false statements about COVID-19 to entice customers to purchase cruises, thus endangering the lives of both their customers and crew members; and (2) as a result, Defendants' statements regarding the Company's business and operations were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Learn about your recoverable losses in NCLH: http://www.kleinstocklaw.com/pslra-1/norwegian-cruise-line-holdings-ltd-loss-submission-form?id=6164&from=1
Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. If you suffered a loss during the class period and wish to obtain additional information, please contact J. Klein, Esq. by telephone at 212-616-4899 or visit the webpages provided.
J. Klein, Esq. represents investors and participates in securities litigations involving financial fraud throughout the nation. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
J. Klein, Esq.
Empire State Building
350 Fifth Avenue
59th Floor
New York, NY 10118
jk@kleinstocklaw.com
Telephone: (212) 616-4899
Fax: (347) 558-9665
www.kleinstocklaw.com
SOURCE: The Klein Law Firm
View source version on accesswire.com:
https://www.accesswire.com/586731/The-Klein-Law-Firm-Reminds-Investors-of-Class-Actions-on-Behalf-of-Shareholders-of-CCI-INO-and-NCLH
